Calidi To Effect 1-for-10 Reverse Stock Split On Jul. 15
Portfolio Pulse from Benzinga Newsdesk
Calidi Biotherapeutics, Inc. (CLDI) will implement a 1-for-10 reverse stock split on July 15. This corporate action is aimed at increasing the stock price by reducing the number of shares outstanding.
July 05, 2024 | 8:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Calidi Biotherapeutics, Inc. (CLDI) will implement a 1-for-10 reverse stock split on July 15. This corporate action is aimed at increasing the stock price by reducing the number of shares outstanding.
A reverse stock split typically aims to increase the stock price by reducing the number of shares outstanding. This can make the stock more attractive to investors and help the company meet listing requirements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100